Supportive Services for Breast Cancer
(ACCESS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment ACCESS Supportive Care, Phone sessions, Lynparza, AZD-2281, MK-7339, KU0059436 for breast cancer?
Supportive care, which includes services like ACCESS Supportive Care and Phone sessions, has been shown to improve the quality of life and manage symptoms for cancer patients, including those with breast cancer. This type of care helps address physical, emotional, and practical needs, which can lead to better overall health outcomes.12345
Is the treatment generally safe for humans?
How does the ACCESS Supportive Care treatment for breast cancer differ from other treatments?
ACCESS Supportive Care is unique because it focuses on addressing the comprehensive needs of breast cancer patients, including managing treatment-related symptoms like fatigue and pain, and providing educational, psychosocial, and spiritual support. This approach aims to improve adherence to treatment and enhance the overall quality of life, which is often overlooked in standard cancer treatments.15111213
What is the purpose of this trial?
Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.
Research Team
Melissa Mazor
Principal Investigator
Icahn School of Medicine at Mount Sinai
Eligibility Criteria
This trial is for women over 18 who identify as Latina or African American/Black, speak English or Spanish, and have been diagnosed with metastatic breast cancer within the last 5 years. They must be able to consent to the study. Women with moderate to severe cognitive issues, in hospice care, or already working with a community navigator can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants complete 6 individualized behavioral/educational sessions focused on social determinants of health and supportive care with a trained community navigator
Follow-up
Participants receive monthly phone call check-ins for 4 months and complete questionnaires at baseline, 6 months, and 9 months
Long-term Follow-up
Participants are monitored for changes in symptom burden and cancer-related distress, with assessments at baseline and 9 months
Treatment Details
Interventions
- ACCESS Supportive Care
- Phone sessions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Cancer Institute (NCI)
Collaborator